InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,962.80
(
-1.27%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.30
(
1.52%
)
Bitcoin
59,385.48
(
-5.97%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BTH

Send PM Follow Ignore
Followers 16
Posts 4145
Boards Moderated 1
Alias Born 06/11/2010

BTH

Re: JJM760 post# 2687

Thursday, 10/21/2010 12:32:25 PM

Thursday, October 21, 2010 12:32:25 PM

Post# of 80490
I have no idea.

That's not for me to decide (or you).

I would think that Merck would be very happy with the results. And, my personal opinion is, they "unblinded" the data before they signed the new deal with Ariad, in order to see if the drug was worth spending more money on. (The trial abstract said that unblinding was "unplanned").

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up